drugset / Trial / NCT00243113

Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

NCT00243113 ↗

Phase 2 Completed 50 enrolled Aichi Cancer Center
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving docetaxel together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving docetaxel together with radiation therapy works in treating patients with stage II or stage III cancer of the larynx or hypopharynx.

Timeline

Start
2004-06
Primary completion
2008-03
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Intravenous

Indications